Inhibition of mitogen stimulated growth of human colon cancer cells by interferon

Br J Cancer. 1988 Aug;58(2):147-51. doi: 10.1038/bjc.1988.182.

Abstract

Recombinant human interferon alpha inhibits growth of a human colon cancer cell line, Colo 205. To explore the mechanisms of IFN induced growth inhibition, quiescent Colo 205 cells were stimulated to proliferate in serum-free media by defined growth factors. Addition of insulin, transferrin and selenium (ITS) stimulated DNA synthesis, as measured by 3H-thymidine incorporation, in a dose-dependent manner. IFN-alpha (at concentrations greater than 100 U ml-1) inhibited ITS stimulated DNA synthesis by 63%. Inhibition of cell cycle traverse was confirmed by flow cytometric analysis. Although IFN inhibited growth of ITS-treated cells, steady state levels of c-myc mRNA remained above levels observed in unstimulated cells. IFN inhibited DNA synthesis only when added prior to mitogen stimulation. IFN, added 6 h after exposure of quiescent cells to ITS, failed to inhibit cell growth. Addition of increasing concentrations of ITS failed to overcome the IFN-induced growth inhibition. These results suggest IFN may inhibit cell growth in part by antagonizing the action of growth factors.

MeSH terms

  • Cell Cycle / drug effects
  • Colonic Neoplasms / metabolism
  • Colonic Neoplasms / pathology*
  • DNA, Neoplasm / biosynthesis
  • Humans
  • Insulin Antagonists / pharmacology
  • Interferon Type I / pharmacology*
  • Mitogens / antagonists & inhibitors
  • Mitosis / drug effects
  • RNA, Messenger / drug effects
  • Selenium / antagonists & inhibitors
  • Time Factors
  • Transferrin / antagonists & inhibitors
  • Tumor Cells, Cultured / drug effects

Substances

  • DNA, Neoplasm
  • Insulin Antagonists
  • Interferon Type I
  • Mitogens
  • RNA, Messenger
  • Transferrin
  • Selenium